FDA Inspection 1089146 — Bloodworks

Bloodworks — FEI 3020842

The FDA completed an inspection of Bloodworks on May 10, 2019 in Bellevue, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bellevue, WA (United States)

Citations

IDCFRDescription
1811421 CFR 630.30(a)(1)Donor deferral